- Home
- NAMS vs PRKS Comparison
NAMS vs PRKS Comparison
Compare NAMS & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- PRKS
- Stock Information
- Founded
- NAMS 2019
- PRKS 1959
- Country
- NAMS Netherlands
- PRKS United States
- Employees
- NAMS N/A
- PRKS N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NAMS Health Care
- PRKS Health Care
- Exchange
- NAMS Nasdaq
- PRKS Nasdaq
- Market Cap
- NAMS 3.1B
- PRKS 2.8B
- IPO Year
- NAMS N/A
- PRKS 2013
- Fundamental
- Price
- NAMS $36.14
- PRKS $51.88
- Analyst Decision
- NAMS Strong Buy
- PRKS Buy
- Analyst Count
- NAMS 10
- PRKS 10
- Target Price
- NAMS $43.70
- PRKS $56.40
- AVG Volume (30 Days)
- NAMS 1.4M
- PRKS 699.9K
- Earning Date
- NAMS 11-06-2025
- PRKS 11-06-2025
- Dividend Yield
- NAMS N/A
- PRKS N/A
- EPS Growth
- NAMS N/A
- PRKS N/A
- EPS
- NAMS N/A
- PRKS 3.77
- Revenue
- NAMS $64,006,000.00
- PRKS $1,707,446,000.00
- Revenue This Year
- NAMS N/A
- PRKS $0.91
- Revenue Next Year
- NAMS $1.67
- PRKS $2.35
- P/E Ratio
- NAMS N/A
- PRKS $13.75
- Revenue Growth
- NAMS 762.15
- PRKS N/A
- 52 Week Low
- NAMS $14.06
- PRKS $37.68
- 52 Week High
- NAMS $41.47
- PRKS $60.83
- Technical
- Relative Strength Index (RSI)
- NAMS 60.09
- PRKS 49.19
- Support Level
- NAMS $34.34
- PRKS $49.69
- Resistance Level
- NAMS $37.21
- PRKS $53.28
- Average True Range (ATR)
- NAMS 2.47
- PRKS 1.77
- MACD
- NAMS -0.34
- PRKS -0.26
- Stochastic Oscillator
- NAMS 46.32
- PRKS 43.89
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.